Overview: Red Blood Cell Count TestIntroduction: The Red Blood Cell Count Test measures RBC count to diagnose anemia or polycythemia, causing fatigue or dizziness. Following 2023 ASH guidelines, it uses hematological methods for high specificity, supporting blood disorder screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in hematology for patients with suspected anemia or polycythemia.
Other Names: RBC Count Assay, Erythrocyte Count Test.
FDA Status: Laboratory-developed test (LDT), meeting hematology standards for diagnostic accuracy.
Historical Milestone: RBC counting began in the 1950s with automated hematology analyzers. Methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures RBC count to diagnose anemia or polycythemia, guides treatment, and evaluates patients with fatigue or dizziness.
Test Parameters: 1. RBC Count
Pretest Condition: No fasting required. Collect whole blood. Report history of fatigue, dizziness, or blood disorder symptoms.
Specimen: Whole Blood (EDTA, 2-5 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fatigue, dizziness, or family history of anemia/polycythemia. Include current medications, especially erythropoietin.
Consent: Written consent required, detailing the tests purpose, anemia/polycythemia implications, and risks of sample collection.
Procedural Considerations: Uses automated hematology analyzers to measure RBC count. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for blood disorder diagnosis.
Factors Affecting Result Accuracy: Improper sample storage or clotting can affect results. Dehydration may falsely elevate RBC count.
Clinical Significance: Low RBC count confirms anemia, guiding iron or vitamin therapy. High count confirms polycythemia, requiring further evaluation.
Specialist Consultation: Consult a hematologist for result interpretation and treatment planning.
Additional Supporting Tests: Hemoglobin, hematocrit, or bone marrow biopsy to confirm anemia/polycythemia diagnosis.
Test Limitations: Non-specific for certain blood disorders; clinical correlation is needed. Sample quality affects sensitivity.
References: ASH Anemia Guidelines, 2023; Blood, Kassebaum NJ, 2022.
